Haematologica, 0390-6078


View graph of relations

Related Publications
  1. Transcription factor 4 (TCF4) expression predicts clinical outcome in RUNX1 mutated and translocated acute myeloid leukemia

    In 't Hout, F. E. M., Gerritsen, M., Bullinger, L., van der Reijden, B. A., Huls, G., Vellenga, E. & Jansen, J. H., 19-Dec-2019, In : Haematologica.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial

    Chamuleau, M. E. D., Burggraaff, C. N., Nijland, M., Bakunina, K., Mous, R., Lugtenburg, P. J., Dierickx, D., van Imhoff, G. W., Vermaat, J. S. P., Marijt, E. A. F., Visser, O., Mandigers, C., Bilgin, Y. M., Beeker, A., Durian, M. F., van Rees, B., Bohmer, L. H., Tick, L. W., Boersma, R. S., Snijders, T. J. F., Schouten, H. C., Koene, H. R., de Jongh, E., Hijmering, N., Diepstra, A., van den Berg, A., Arens, A. I. J., Huijbregts, J., Hoekstra, O., Zijlstra, J. M., de Jong, D. & Kersten, M. J., 19-Dec-2019, In : Haematologica.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness-genes and can be targeted by the BCL2 inhibitor Venetoclax

    Mattes, K., Gerritsen, M., Folkerts, H., Geugien, M., van den Heuvel, F. A., Flohr Svendsen, A., Yi, G., Martens, J. H. A. & Vellenga, E., 14-Nov-2019, In : Haematologica.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Bortezomib based induction followed by stem cell transplantation in light chain amyloidosis: results of the multicenter HOVON 104 trial

    Minnema, M. C., Nasserinejad, K., Hazenberg, B., Hegenbart, U., Vlummens, P., Ypma, P. F., Kröger, N., Wu, K. L., Kersten, M. J., Schaafsma, M. R., Croockewit, S., de Waal, E., Zweegman, S., Tick, L., Broijl, A., Koene, H., Bos, G., Sonneveld, P. & Schönland, S., Nov-2019, In : Haematologica. 104, 11, p. 2274-2282 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  5. Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma

    Broijl, A., Kersten, M. J., Alemayehu, W. G., Levin, M. D., de Weerdt, O., Vellenga, E., Meijer, E., Wittebol, S., Tanis, B. C., Cornelisse, P. B., Stevens-Kroef, M., Bos, G. M. J., Wijermans, P. W., Lokhorst, H. & Sonneveld, P., 31-Mar-2016, In : Haematologica. 101, 4, p. e149-e152

    Research output: Contribution to journalLetterAcademicpeer-review

View all (124) »

ID: 1556195